Recombinant; Rabbit anti Human Presenilin 2/AD5 Antibody; WB; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab123032-10μl | 10μl | In stock | $66.90 | |
| Ab123032-50μl | 50μl | In stock | $189.90 | |
| Ab123032-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $299.90 | |
| Ab123032-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,699.90 |
Recombinant; Rabbit anti Human Presenilin 2/AD5 Antibody; WB; Unconjugated
| Product Name | Recombinant Presenilin 2/AD5 Antibody - Primary antibody, specific to PSEN2, Rabbit IgG |
|---|---|
| Synonyms | AD3L; AD4; CMD1V; PS2; STM2; AD3LP; AD4AD3L; AD5; E5-1; EC 3.4.23; EC 3.4.23.-; presenilin 2 (Alzheimer disease 4); Presenilin2; Presenilin-2; PS-2; PS2CMD1V; PSEN2; PSNL2; STM2STM-2；AD3L antibody; AD3LP antibody; AD4 antibody; AD5 antibody; Alzheimer dis |
| Specifications & Purity | ExactAb™, Validated, Recombinant, 0.5 mg/mL |
| Host species | Rabbit |
| Specificity | PSEN2 |
| Immunogen | A synthetic peptide derived from human Presenilin 2 (AA 317-334). |
| Positive Control | WB: C6, NIH/3T3, HeLa, Hep G2, A549 and HEK293 cell lysates. |
| Conjugation | Unconjugated |
| Grade | ExactAb™, Recombinant, Validated |
| Product Description | Rabbit anti Human Presenilin 2/AD5 Antibody, Recombinant, could be used for WB and so on. |
| Isotype | Rabbit IgG |
|---|---|
| SDS-PAGE | 150 kDa |
| Purification Method | Antigen affinity purified |
| Form | Liquid |
| Concentration | 0.5 mg/mL |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Recombinant Presenilin 2/AD5 Antibody (Ab123032) - Western Blot
All lanes: Recombinant Presenilin 2/AD5 Antibody (Ab123032) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 21 kDa
Exposure time: 46.7 s
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Application | Dilution info |
|---|---|
| WB | 1/500-1/1000 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0202728 | Certificate of Analysis | Feb 05, 2024 | Ab123032 |
| ZJ24F0202727 | Certificate of Analysis | Feb 05, 2024 | Ab123032 |
| 1. Probst G, Aubele DL, Bowers S, Dressen D, Garofalo AW, Hom RK, Konradi AW, Marugg JL, Mattson MN, Neitzel ML et al.. (2013) Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over Notch.. J Med Chem, 56 (13): (5261-74). [PMID:23713656] |
| 2. Wu WL, Domalski M, Burnett DA, Josien H, Bara T, Rajagopalan M, Xu R, Clader J, Greenlee WJ, Brunskill A et al.. (2012) Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease.. ACS Med Chem Lett, 3 (11): (892-6). [PMID:24900404] |
| 3. Kumar R, Juillerat-Jeanneret L, Golshayan D. (2016) Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.. J Med Chem, 59 (17): (7719-37). [PMID:27045975] |
| 4. Kumar D, Ganeshpurkar A, Kumar D, Modi G, Gupta SK, Singh SK. (2018) Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.. Eur J Med Chem, 148 (3): (436-452). [PMID:29477076] |
| 5. Sharon Gauci,Andreas O Helbig,Monique Slijper,Jeroen Krijgsveld,Albert J R Heck,Shabaz Mohammed. (2009-05-06) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.. Analytical chemistry, 81 ((11)): (4493-4501). [PMID:19413330] |
| 6. Churcher I, Beher D, Best JD, Castro JL, Clarke EE, Gentry A, Harrison T, Hitzel L, Kay E, Kerrad S, Lewis HD, Morentin-Gutierrez P, Mortishire-Smith R, Oakley PJ, Reilly M, Shaw DE, Shearman MS, Teall MR, Williams S, Wrigley JD.. (2006) 4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.. Bioorg Med Chem Lett, 16 (2): (280-284). [PMID:16275079] |
| 7. Narlawar R, Pérez Revuelta BI, Baumann K, Schubenel R, Haass C, Steiner H, Schmidt B.. (2007) N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase.. Bioorg Med Chem Lett, 17 (1): (176-182). [PMID:17035010] |
| 8. Prasad CV, Zheng M, Vig S, Bergstrom C, Smith DW, Gao Q, Yeola S, Polson CT, Corsa JA, Guss VL, Loo A, Wang J, Sleczka BG, Dangler C, Robertson BJ, Hendrick JP, Roberts SB, Barten DM.. (2007) Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's disease.. Bioorg Med Chem Lett, 17 (14): (4006-4011). [PMID:17502137] |
| 9. Narlawar R, Baumann K, Czech C, Schmidt B.. (2007) Conversion of the LXR-agonist TO-901317--from inverse to normal modulation of gamma-secretase by addition of a carboxylic acid and a lipophilic anchor.. Bioorg Med Chem Lett, 17 (19): (5428-5431). [PMID:17723298] |
| 10. Kitas EA, Galley G, Jakob-Roetne R, Flohr A, Wostl W, Mauser H, Alker AM, Czech C, Ozmen L, David-Pierson P, Reinhardt D, Jacobsen H.. (2008) Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.. Bioorg Med Chem Lett, 18 (1): (304-308). [PMID:17983746] |
| 11. Czirr E, Leuchtenberger S, Dorner-Ciossek C, Schneider A, Jucker M, Koo EH, Pietrzik CU, Baumann K, Weggen S.. (2007) Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.. J Biol Chem, 282 (34): (24504-24513). [PMID:17573346] |
| 12. Yang G, Yin YI, Chun J, Shelton CC, Ouerfelli O, Li YM.. (2009) Stereo-controlled synthesis of novel photoreactive gamma-secretase inhibitors.. Bioorg Med Chem Lett, 19 (3): (922-925). [PMID:19097779] |
| 13. Pu J, Kreft AF, Aschmies SH, Atchison KP, Berkowitz J, Caggiano TJ, Chlenov M, Diamantidis G, Harrison BL, Hu Y, Huryn D, Steven Jacobsen J, Jin M, Lipinski K, Lu P, Martone RL, Morris K, Sonnenberg-Reines J, Riddell DR, Sabalski J, Sun SC, Wagner E, Wang Y, Xu Z, Zhou H, Resnick L.. (2009) Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.. Bioorg Med Chem, 17 (13): (4708-4717). [PMID:19443228] |
| 14. Rivkin A, Ahearn SP, Chichetti SM, Kim YR, Li C, Rosenau A, Kattar SD, Jung J, Shah S, Hughes BL, Crispino JL, Middleton RE, Szewczak AA, Munoz B, Shearman MS.. (2010) Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.. Bioorg Med Chem Lett, 20 (3): (1269-1271). [PMID:20022243] |
| 15. Rivkin A, Ahearn SP, Chichetti SM, Hamblett CL, Garcia Y, Martinez M, Hubbs JL, Reutershan MH, Daniels MH, Siliphaivanh P, Otte KM, Li C, Rosenau A, Surdi LM, Jung J, Hughes BL, Crispino JL, Nikov GN, Middleton RE, Moxham CM, Szewczak AA, Shah S, Moy LY, Kenific CM, Tanga F, Cruz JC, Andrade P, Angagaw MH, Shomer NH, Miller T, Munoz B, Shearman MS.. (2010) Purine derivatives as potent gamma-secretase modulators.. Bioorg Med Chem Lett, 20 (7): (2279-2282). [PMID:20207146] |
| 16. Crump CJ, am Ende CW, Ballard TE, Pozdnyakov N, Pettersson M, Chau DM, Bales KR, Li YM, Johnson DS.. (2012) Development of clickable active site-directed photoaffinity probes for γ-secretase.. Bioorg Med Chem Lett, 22 (8): (2997-3000). [PMID:22418280] |
| 17. Close J, Heidebrecht R, Hendrix J, Li C, Munoz B, Surdi L, Kattar S, Tempest P, Moses P, Geng X, Hughes B, Smotrov N, Moxham C, Chapnick J, Kariv I, Nikov G, Burke JE, Deshmukh S, Jeliazkova-Mecheva V, Leach JK, Diaz D, Xu L, Yang Z, Kwei G, Moy L, Shah S, Tanga F, Kenefic C, Savage D, Shearman M, Ball RG, McNevin MJ, Markarewicz A, Miller T.. (2012) Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitors.. Bioorg Med Chem Lett, 22 (9): (3203-3207). [PMID:22483609] |
| 18. Liu Y, Zhang W, Li L, Salvador LA, Chen T, Chen W, Felsenstein KM, Ladd TB, Price AR, Golde TE, He J, Xu Y, Li Y, Luesch H.. (2012) Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.. J Med Chem, 55 (23): (10749-10765). [PMID:23181502] |
| 19. Huang X, Zhou W, Liu X, Li H, Sun G, Mandal M, Vicarel M, Zhu X, Bennett C, McCraken T, Pissarnitski D, Zhao Z, Cole D, Gallo G, Zhu Z, Palani A, Aslanian R, Clader J, Czarniecki M, Greenlee W, Burnett D, Cohen-Williams M, Hyde L, Song L, Zhang L, Chu I, Buevich A.. (2012) Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease.. ACS Med Chem Lett, 3 (11): (931-935). [PMID:24900409] |
| 20. Amombo GM, Kramer T, Lo Monte F, Göring S, Fach M, Smith S, Kolb S, Schubenel R, Baumann K, Schmidt B.. (2012) Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.. Bioorg Med Chem Lett, 22 (24): (7634-7640). [PMID:23107479] |
| 21. Li H, Qin J, Dhondi P, Zhou W, Vicarel M, Bara T, Cole D, Josien H, Pissarnitski D, Zhu Z, Palani A, Aslanian R, Clader J, Czarniecki M, Greenlee W, Cohen-Williams M, Hyde L, Song L, Zhang L, Chu I, Huang X.. (2013) The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.. Bioorg Med Chem Lett, 23 (2): (466-471). [PMID:23253441] |
| 22. Wu WL, Asberom T, Bara T, Bennett C, Burnett DA, Clader J, Domalski M, Greenlee WJ, Josien H, McBriar M, Rajagopalan M, Vicarel M, Xu R, Hyde LA, Del Vecchio RA, Cohen-Williams ME, Song L, Lee J, Terracina G, Zhang Q, Nomeir A, Parker EM, Zhang L.. (2013) Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.. Bioorg Med Chem Lett, 23 (3): (844-849). [PMID:23265892] |
| 23. Imamura Y, Umezawa N, Osawa S, Shimada N, Higo T, Yokoshima S, Fukuyama T, Iwatsubo T, Kato N, Tomita T, Higuchi T.. (2013) Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.. J Med Chem, 56 (4): (1443-1454). [PMID:23342950] |
| 24. Gertsik N, Ballard TE, Am Ende CW, Johnson DS, Li YM.. (2014) Development of CBAP-BPyne, a probe for γ-secretase and presenilinase.. Medchemcomm, 5 (3): (338-341). [PMID:24914408] |
| 25. Flesch D, Ness J, Lamers C, Dehm F, Popella S, Steri R, Ogorek I, Hieke M, Dannhardt G, Werz O, Weggen S, Schubert-Zsilavecz M.. (2015) SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.. Bioorg Med Chem Lett, 25 (4): (841-846). [PMID:25575659] |
| 26. Methot JL, Fischer C, Li C, Rivkin A, Ahearn SP, Brown WC, Kattar S, Kelley E, Mampreian DM, Schell A, Rosenau A, Zhou H, Ball R, Deshmukh SV, Jeliazkova-Mecheva VV, Diaz D, Moy LY, Kenific CM, Moxham C, Shah S, Nuthall H, Szewczak AA, Hill A, Hughes B, Smotrov N, Munoz B, Miller TA, Shearman MS.. (2015) Potent benzoazepinone γ-secretase modulators with improved bioavailability.. Bioorg Med Chem Lett, 25 (17): (3495-3500). [PMID:26142947] |
| 27. Zhao Z, Pissarnitski DA, Josien HB, Wu WL, Xu R, Li H, Clader JW, Burnett DA, Terracina G, Hyde L, Lee J, Song L, Zhang L, Parker EM.. (2015) Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.. J Med Chem, 58 (22): (8806-8817). [PMID:26496070] |
| 28. Lu D, Wei HX, Zhang J, Gu Y, Osenkowski P, Ye W, Selkoe DJ, Wolfe MS, Augelli-Szafran CE.. (2016) Part 1: Notch-sparing γ-secretase inhibitors: The identification of novel naphthyl and benzofuranyl amide analogs.. Bioorg Med Chem Lett, 26 (9): (2129-2132). [PMID:27013392] |
| 29. Wei HX, Lu D, Sun V, Zhang J, Gu Y, Osenkowski P, Ye W, Selkoe DJ, Wolfe MS, Augelli-Szafran CE.. (2016) Part 2. Notch-sparing γ-secretase inhibitors: The study of novel γ-amino naphthyl alcohols.. Bioorg Med Chem Lett, 26 (9): (2133-2137). [PMID:27020305] |
| 30. Yoneyama T, Arai MA, Akamine R, Koryudzu K, Tsuchiya A, Sadhu SK, Ahmed F, Itoh M, Okamoto R, Ishibashi M.. (2017) Notch Inhibitors from Calotropis gigantea That Induce Neuronal Differentiation of Neural Stem Cells.. J Nat Prod, 80 (9): (2453-2461). [PMID:28817274] |
| 31. Sekioka R, Honjo E, Honda S, Fuji H, Akashiba H, Mitani Y, Yamasaki S.. (2018) Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.. Bioorg Med Chem, 26 (2): (435-442). [PMID:29249626] |
| 32. Mekala, Shekar, Nelson, Grady, Li, Yue-Ming. (2020) Recent developments of small molecule gamma-secretase modulators for Alzheimer''s disease. RSC Med Chem, 11 (9): (1003-1022). [PMID:33479693] |
| 33. Boy KM,Guernon JM,Zuev DS,Xu L,Zhang Y,Shi J,Marcin LR,Higgins MA,Wu YJ,Krishnananthan S,Li J,Trehan A,Smith D,Toyn JH,Meredith JE,Burton CR,Kimura SR,Zvyaga T,Zhuo X,Lentz KA,Grace JE,Denton R,Morrison JS,Mathur A,Albright CF,Ahlijanian MK,Olson RE,Thompson LA,Macor JE. (2019) Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481.. ACS Med Chem Lett, 10 (3): (312-317). [PMID:30891132] |
| 34. Levy-Lahad, E E and 9 more authors.. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus.. Science (New York, N.Y.), (18): [PMID:7638622] |
| 35. Rogaev, E I EI and 9 more authors.. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.. Nature, (31): [PMID:7651536] |
| 36. Kovacs, D M DM and 12 more authors.. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.. Nature medicine, [PMID:8574969] |
| 37. Li, J J, Ma, J J and Potter, H H.. (1995) Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3.. Proceedings of the National Academy of Sciences of the United States of America, (19): [PMID:8618867] |
| 38. Levy-Lahad, E E and 6 more authors.. (1996) Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene.. Genomics, (1): [PMID:8661049] |
| 39. Cruts, M M and 11 more authors.. (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.. Human molecular genetics, [PMID:9384602] |
| 40. Zhang, W W, Han, S W SW, McKeel, D W DW, Goate, A A and Wu, J Y JY.. (1998) Interaction of presenilins with the filamin family of actin-binding proteins.. The Journal of neuroscience : the official journal of the Society for Neuroscience, (1): [PMID:9437013] |
| 41. Cruts, M M and Van Broeckhoven, C C.. (1998) Presenilin mutations in Alzheimer's disease.. Human mutation, [PMID:9521418] |
| 42. Steiner, H H and 18 more authors.. (1999) A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling.. The Journal of biological chemistry, (1): [PMID:10497236] |
| 43. Finckh, U U and 10 more authors.. (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.. American journal of human genetics, [PMID:10631141] |
| 44. Kimberly, W T WT, Xia, W W, Rahmati, T T, Wolfe, M S MS and Selkoe, D J DJ.. (2000) The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation.. The Journal of biological chemistry, (4): [PMID:10652302] |
| 45. Lao, J I JI, Beyer, K K, Fernández-Novoa, L L and Cacabelos, R R.. (1998) A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset Alzheimer's disease.. Neurogenetics, [PMID:10732806] |
| 46. Sai, Xiaorei X and 12 more authors.. (2002) Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein.. The Journal of biological chemistry, (12): [PMID:11799129] |
| 47. Binetti, Giuliano G and 16 more authors.. (2003) Atypical dementia associated with a novel presenilin-2 mutation.. Annals of neurology, [PMID:14681895] |
| 48. Friedmann, Elena E and 6 more authors.. (2004) Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins.. The Journal of biological chemistry, (3): [PMID:15385547] |
| 49. Gregory, S G SG and 178 more authors.. (2006) The DNA sequence and biological annotation of human chromosome 1.. Nature, (18): [PMID:16710414] |
| 50. Kumar-Singh, Samir S and 9 more authors.. (2006) Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.. Human mutation, [PMID:16752394] |
| 51. Tu, Huiping H and 9 more authors.. (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations.. Cell, (8): [PMID:16959576] |
| 52. Li, Duanxiang D and 12 more authors.. (2006) Mutations of presenilin genes in dilated cardiomyopathy and heart failure.. American journal of human genetics, [PMID:17186461] |
| 53. Zampese, Enrico E and 5 more authors.. (2011) Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.. Proceedings of the National Academy of Sciences of the United States of America, (15): [PMID:21285369] |
| 54. Piscopo, Paola P and 10 more authors.. (2011) Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case.. Journal of neurology, [PMID:21544564] |
| 55. Lohmann, Ebba E and 9 more authors.. (2012) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.. Neurobiology of aging, [PMID:22503161] |
| 56. Niu, Fusheng F and 10 more authors.. (2014) Novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer's disease in a Chinese Han family.. Neurobiology of aging, [PMID:24838186] |
| 57. Müller, Ulrich U, Winter, Pia P, Bolender, Claus C and Nolte, Dagmar D.. (2014) Previously unrecognized missense mutation E126K of PSEN2 segregates with early onset Alzheimer's disease in a family.. Journal of Alzheimer's disease : JAD, [PMID:24844686] |
